Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697
نویسندگان
چکیده
This article responds to:Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England
منابع مشابه
Thymectomy in Patients with Myasthenia Gravis
A case of myasthenia gravis in a 15 years old girl is pre·sented. The disease was present for 5 years before thymectomy was performed. Indications for thymectomy, preoperative preparation, anesthetic and surgical management is -discussed.
متن کاملTreatment for refractory myasthenia gravis.
An 8 year old girl with ocular myasthenia gravis was treated with high dose intravenous immunoglobulin and high dose intravenous methylprednisolone. Ocular symptoms recurred seven months after the start of the immunoglobulin. She has been in remission for more than 12 months after two courses of intravenous methylprednisolone, and administration of oral prednisolone was discontinued.
متن کاملImmunoglobulin treatment in refractory Myasthenia gravis.
Failure to induce and maintain remission in severe exacerbations of myasthenia gravis (MG), despite optimal care, is a common problem. We evaluated the efficacy and safety of high-dose intravenous immunoglobulin (IVIg) therapy in an open-label study of 10 patients with severe generalized myasthenia and an acute deterioration unresponsive to conventional therapy including high-dose corticosteroi...
متن کاملClinical Characteristics of Refractory Myasthenia Gravis Patients
BACKGROUND A subset of myasthenia gravis (MG) patients is refractory to standard therapies. Identifying the characteristics of this population is essential as newer treatment strategies emerge that may be more effective in this group. OBJECTIVE The aim of our study is to describe the clinical features of refractory MG patients and compare them to those of non-refractory patients. METHODS A ...
متن کاملLong-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin
Introduction Myasthenia gravis (MG) is an autoimmune disease characterized by fatigue and weakness of skeletal muscles. Laryngeal myasthenia (when dysphonia is the initial and primary complaint) is a rare variant of MG (0.46%),1 which may provide a diagnostic challenge. Although with adequate treatment majority of myasthenic patients can live productive lives with no or few symptoms, there is a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Medical Economics
سال: 2021
ISSN: ['1369-6998', '1941-837X']
DOI: https://doi.org/10.1080/13696998.2021.1948732